Three out of five pharmaceutical market research studies—60 % of those fielded in the US and abroad—were conducted online last year, a new study shows.

Cephalon EVP, general counsel and secretary John Osborn will resign effective March 31.

Steve Case, chairman and CEO of Revolution Health and co-founder of AOL, yesterday lamented pharma's hesitation to embrace interactive and inject a greater share of promotional budget into online initiatives.

GlaxoSmithKline awarded its online professional media buying and planning business to Communications Media, Inc.

Solvay Pharmaceuticals CEO Laurence Downey, MD, will retire effective April 30th and will be succeeded by Stephen Hill, the Marietta, GA, firm said in a statement.

While data mining laws are mired in the courts, a number of alternatives are proliferating to help states manage costs and help physicians control encounters with sales reps.

Pharmaceutical promotion measurement firm ImpactRx has acquired Paragon Research & Consulting, Inc. of West Chester, PA.

Vermont amended its data mining law to avoid constitutional issues that, so far, have undermined similar statutes in other states.

IMS Health announced the launch of its IMS Precision Compensation offering to help pharmaceutical companies optimize their sales force incentive compensation programs and gain additional cost efficiencies.

A major funder of CME is trying to win back accredited education providers who may have been turned off by pharma's newer grant application systems.